Citadel Advisors’s Relay Therapeutics RLAY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.75M Buy
176,265
+62,122
+54% +$556K ﹤0.01% 6366
2025
Q4
$966K Buy
+114,143
New +$815K ﹤0.01% 7471
2025
Q3
Hold
0
14082
2025
Q2
Sell
-337,268
Closed -$1M 14856
2025
Q1
$884K Sell
337,268
-349,610
-51% -$1.37M ﹤0.01% 7241
2024
Q4
$2.83M Sell
686,878
-2,222,493
-76% -$12.1M ﹤0.01% 4934
2024
Q3
$20.6M Buy
2,909,371
+1,746,035
+150% +$13M 0.02% 2022
2024
Q2
$7.58M Buy
1,163,336
+926,136
+390% +$6.33M 0.01% 3166
2024
Q1
$1.97M Sell
237,200
-360,394
-60% -$3.52M ﹤0.01% 5552
2023
Q4
$6.58M Sell
597,594
-1,085,255
-64% -$9.16M 0.01% 3420
2023
Q3
$14.2M Buy
1,682,849
+1,374,834
+446% +$14.8M 0.02% 2261
2023
Q2
$3.87M Buy
308,015
+287,296
+1,387% +$3.57M ﹤0.01% 4037
2023
Q1
$341K Sell
20,719
-113,641
-85% -$2.04M ﹤0.01% 9113
2022
Q4
$2.01M Sell
134,360
-118,380
-47% -$2.27M ﹤0.01% 5484
2022
Q3
$5.65M Buy
252,740
+223,821
+774% +$4.91M 0.01% 3671
2022
Q2
$484K Sell
28,919
-71,175
-71% -$1.53M ﹤0.01% 8732
2022
Q1
$3M Sell
100,094
-152,665
-60% -$3.7M ﹤0.01% 5186
2021
Q4
$7.76M Buy
252,759
+66,512
+36% +$2.1M 0.01% 3509
2021
Q3
$5.87M Buy
186,247
+58,996
+46% +$1.99M 0.01% 4000
2021
Q2
$4.66M Buy
127,251
+478
+0.4% +$15.8K ﹤0.01% 4602
2021
Q1
$4.38M Buy
126,773
+63,776
+101% +$2.77M ﹤0.01% 4560
2020
Q4
$2.62M Buy
62,997
+8,904
+16% +$403K ﹤0.01% 4807
2020
Q3
$2.3M Buy
+54,093
New +$2.06M ﹤0.01% 4463

Other funds holding RLAY